Catalyst Wire Dossier Catalyst Wire Dossier

Rivastigmine transdermal system

Rivastigmine · Breckenridge Pharmaceutical, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Rivastigmine transdermal system, covering 2019-11-26 to 2022-03-07. Get the full timeline:

Most recent: Clinical Trial Update: Effect of Heat on Rivastigmine TDS Products [EARLY_Phase 1]

See pricing